All News

FDA Approves Retevmo for Some With Medullary Thyroid Cancer

September 27th 2024, 7:48pm

Article

The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.

Prostate Cancer Questions Answered on Surgery, Side Effects and More

September 27th 2024, 7:00pm

Article

An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.

There is Nothing Pink About Breast Cancer

September 27th 2024, 5:00pm

Article

As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.

Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More

September 27th 2024, 3:00pm

Article

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

Supplemental New Drug Application Submitted for Nubeqa in Prostate Cancer Subset

September 27th 2024, 1:00pm

Article

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer

September 26th 2024, 9:00pm

Article

A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.

Palliative Care in Kidney Cancer More Than Just Relieving Symptoms

September 26th 2024, 7:00pm

Article

Patients with kidney cancer who want more support during treatment can consider palliative care, whether it’s for symptoms or discussing goals and values.

3 Ways You Can Participate in Mesothelioma Awareness Day

September 26th 2024, 5:00pm

Article

As a cancer survivor, I’ve found three impactful ways to get involved in Mesothelioma Awareness Day to help make a difference.

Kidney Cancer Questions Answered, From Protein Intake to Clinical Trials

September 26th 2024, 3:00pm

Article

An expert provides answers to readers’ questions regarding different aspects of the kidney cancer experience, such as protein intake and clinical trials.

Imjudo Plus Imfinzi Improve Survival Versus Nexavar in Liver Cancer

September 26th 2024, 1:00pm

Article

In patients with unresectable liver cancer, treatment with Imjudo plus Imfinzi showed better survival outcomes compared with Nexavar.